| Predicate |
Object |
| contentType |
Journal Article |
| issn |
0890-9091 |
| issueIdentifier |
9 |
| pageRange |
841- |
| publicationName |
Oncology (Williston Park, N.Y.) |
| startingPage |
841 |
| bibliographicCitation |
FDA approves liposomal vincristine (Marqibo) for rare leukemia. Oncology (Williston Park). 2012 Sep;26(9):841. PMID: 23061340. |
| date |
201209 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/23061340 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1783
https://portal.issn.org/resource/ISSN/0890-9091 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
FDA approves liposomal vincristine (Marqibo) for rare leukemia |
| discusses |
http://id.nlm.nih.gov/mesh/M0012600
http://id.nlm.nih.gov/mesh/M0001486
http://id.nlm.nih.gov/mesh/M0006822
http://id.nlm.nih.gov/mesh/M0022676 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D054198Q000188
http://id.nlm.nih.gov/mesh/D017277
http://id.nlm.nih.gov/mesh/D004337
http://id.nlm.nih.gov/mesh/D014750Q000008
http://id.nlm.nih.gov/mesh/D000972Q000008 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D014486
http://id.nlm.nih.gov/mesh/D015337
http://id.nlm.nih.gov/mesh/D017322
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D008081
http://id.nlm.nih.gov/mesh/D007390
http://id.nlm.nih.gov/mesh/D014481 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3717450
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID138911098
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296921
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID249332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164145
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134755071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45358158 |